TLSA CIK: 1723069

Tiziana Life Sciences Ltd

  • United Kingdom
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
48.7
FY22:
24.3
FY23:
7.34
FY24:
7.51
FY25:
8.55
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.15
FY22:
2.20
FY23:
4.85
FY24:
3.78
FY25:
2.94
Total assets
Change from FY21 to FY25
millions USD
FY21:
48.8
FY22:
26.5
FY23:
12.2
FY24:
11.3
FY25:
11.5

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
7.55
FY22:
6.66
FY23:
6.54
FY24:
7.35
FY25:
11.2
(negative)
millions USD
FY21:
0
FY22:
0.24
FY23:
0.11
FY24:
0
FY25:
0.23
(positive)
Change from FY21 to FY25
millions USD
FY21:
41.3
FY22:
19.6
FY23:
5.54
FY24:
3.94
FY25:
0.05
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
48.8
FY22:
26.5
FY23:
12.2
FY24:
11.3
FY25:
11.5

All amounts in millions USD Data source:SEC EDGAR